JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1

被引:23
|
作者
Yu, Luyang [1 ]
Min, Wang [1 ,2 ]
He, Yun [1 ]
Qin, Lingfeng [1 ]
Zhang, Haifeng [1 ]
Bennett, Anton M. [3 ]
Chen, Hong [4 ]
机构
[1] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, Dept Pathol, New Haven, CT 06520 USA
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China
[3] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
[4] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
基金
美国国家卫生研究院;
关键词
TUMOR-NECROSIS-FACTOR; FLUID SHEAR-STRESS; ASK1-MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; INDEPENDENT MANNER; INHIBITOR; 14-3-3; FAMILY-MEMBERS; KINASE; ACTIVATION; DISSOCIATION;
D O I
10.1074/jbc.M809740200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously we have shown that tyrosine 718 of ASK1 when phosphorylated is critical for SOCS1 binding and SOCS1-mediated degradation of ASK1. However, the kinase and phosphatase responsible for phosphorylation and dephosphorylation of ASK1 at Tyr-718 are unknown. In this study, we identified JAK2 and SHP2 as a Tyr-718-specific kinase and phosphatase, respectively. Interferon-gamma (IFN-gamma) induced degradation of ASK1 in normal but not in SOCS1-KO endothelial cells (EC). IFN-gamma-induced tyrosine phosphorylation of ASK1 at Tyr-718 was blocked by a JAK2-specific inhibitor. IFN-gamma enhanced the association between JAK2 and ASK1, and the ASK1-JAK2 complex was labile and was stabilized by the proteasomal inhibitor MG132. Furthermore, JAK2, but not JAK1, directly bound to and phosphorylated ASK1 at Tyr-718, leading to an enhanced association of ASK1 with SOCS1 and subsequent ASK1 degradation. Next, we showed that overexpression of the SH2-containing protein-tyrosine phosphatase-2 (SHP2) augmented, whereas a phosphatase-inactive mutant of SHP2 inhibited, TNF-induced ASK1 dephosphorylation. SHP2 associated with ASK1 in response to tumor necrosis factor in EC. An SHP-2 substrate-trapping mutant formed a complex with tyrosine-phosphorylated ASK1, suggesting that ASK1 is a direct SHP2 substrate. Moreover, SHP2 wild type, but not a catalytically inactive mutant, dissociated SOCS1 from ASK1. IFN-gamma-induced ASK1 Tyr(P)-718 was enhanced in mouse EC deficient in SHP2 (SHP2-KO). In contrast, tumor necrosis factor-induced dephosphorylation of ASK1 at Tyr(P)-718 and activation of ASK1-JNK signaling, as well as EC apoptosis, are significantly reduced in SHP2-KO EC. Our data suggest that JAK2-SOCS1 and SHP2 reciprocally regulate ASK1 phosphorylation and stability in response to cytokines.
引用
收藏
页码:13481 / 13488
页数:8
相关论文
共 50 条
  • [1] Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2
    Marrero, MB
    Venema, VJ
    Ju, H
    Eaton, DC
    Venema, RC
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (05): : C1216 - C1223
  • [2] PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice
    Banno, Ryoichi
    Zimmer, Derek
    De Jonghe, Bart C.
    Atienza, Marybiess
    Rak, Kimberly
    Yang, Wentian
    Bence, Kendra K.
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (03): : 720 - 734
  • [3] The role of the protein tyrosine phosphatase SHP2 in ossification
    Zhang, Yuan
    Lu, Wei
    Zhao, Qing
    Chen, Jindong
    Wang, Tiancong
    Ji, Jun
    DEVELOPMENTAL DYNAMICS, 2022, 251 (05) : 748 - 758
  • [4] The Landscape of Protein Tyrosine Phosphatase (Shp2) and Cancer
    Rehman, Ashfaq Ur
    Rahman, Mueed Ur
    Khan, Muhammad T.
    Saud, Shah
    Liu, Hao
    Song, Dong
    Sultana, Pinky
    Wadood, Abdul
    Chen, Hai-Feng
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (32) : 3767 - 3777
  • [5] Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation
    McDoom, Issam
    Ma, Xianyue
    Kirabo, Annet
    Lee, Kuang-Yung
    Ostrov, David A.
    Sayeski, Peter P.
    BIOCHEMISTRY, 2008, 47 (32) : 8326 - 8334
  • [6] SHP2 Inhibition Enhances JAK2 Inhibitor Therapy in Preclinical Models of Myeloproliferative Neoplasms
    Pandey, Garima
    Mazzacurati, Lucia
    Horvat, Nathan P.
    Rowsell, Tegan
    Amin, Narmin E.
    Zhang, Guolin
    Akuffo, Afua Adutwumwa
    Colin-Leitzinger, Christelle M.
    Haura, Eric B.
    Kuykendall, Andrew T.
    Epling-Burnette, P. K.
    Reuther, Gary W.
    BLOOD, 2023, 142
  • [7] Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
    Chen, Chuan
    Cao, Mengmeng
    Zhu, Siyu
    Wang, Cuicui
    Liang, Fan
    Yan, Leilei
    Luo, Duqiang
    SCIENTIFIC REPORTS, 2015, 5
  • [8] Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
    Chuan Chen
    Mengmeng Cao
    Siyu Zhu
    Cuicui Wang
    Fan Liang
    Leilei Yan
    Duqiang Luo
    Scientific Reports, 5
  • [9] Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor
    Chen, Liwei
    Sung, Shen-Shu
    Yip, M. L. Richard
    Lawrence, Harshani R.
    Ren, Yuan
    Guida, Wayne C.
    Sebti, Said M.
    Lawrence, Nicholas J.
    Wu, Jie
    MOLECULAR PHARMACOLOGY, 2006, 70 (02) : 562 - 570
  • [10] Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention
    Butterworth, Sam
    Overduin, Michael
    Barr, Alastair J.
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (12) : 1423 - 1437